Literature DB >> 24305841

Sinonasal natural killer/T-cell lymphoma presenting as pyrexia of unknown origin with nasal symptoms.

Betsy K H Soon, Xin-Rong Lim, Deborah H L Ng, Ming-Yann Lim.   

Abstract

A 68-year-old Chinese man presented with an eight-month history of pyrexia of unknown origin and chronic sinusitis despite multiple courses of antibiotics. He underwent extensive investigations, including workups for infections, chronic granulomatous diseases and malignancy. Nasal biopsies were performed twice under local anaesthesia, but did not show any evidence of malignancy. Eventually, the patient was diagnosed with natural killer (NK)/T-cell lymphoma, nasal variant, based on histopathological findings from harvested deep tissue obtained via functional endoscopic sinus surgery. This study highlights that, for patients presenting with pyrexia of unknown origin and nasal symptoms, NK/T-cell lymphoma must be considered as a differential diagnosis. Generous amounts of tissue should be harvested under general anaesthesia rather than limited tissue under local anaesthesia, in order to facilitate and ensure a definitive diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24305841      PMCID: PMC4291970          DOI: 10.11622/smedj.2013210

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  12 in total

1.  Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital.

Authors:  I Cuadra-Garcia; G M Proulx; C L Wu; C C Wang; B Z Pilch; N L Harris; J A Ferry
Journal:  Am J Surg Pathol       Date:  1999-11       Impact factor: 6.394

2.  Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy.

Authors:  Ivan Weng Keong Tham; Khai Mun Lee; Swee Peng Yap; Susan Li-Er Loong
Journal:  Head Neck       Date:  2006-02       Impact factor: 3.147

3.  Primary nasal non-Hodgkin lymphomas presented initially as benign disease.

Authors:  Dionysios E Kyrmizakis; Jiannis K Hajiioannou; Anastasios V Koutsopoulos; Eleni Papadaki; Dimitrios Papadakis; John Bizakis; George Velegrakis
Journal:  Am J Otolaryngol       Date:  2006 May-Jun       Impact factor: 1.808

4.  Nasal lymphoma. A retrospective analysis of 60 cases.

Authors:  R Liang; D Todd; T K Chan; E Chiu; D Choy; S L Loke; F C Ho
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

Review 5.  Staging non-Hodgkin lymphoma.

Authors:  James O Armitage
Journal:  CA Cancer J Clin       Date:  2005 Nov-Dec       Impact factor: 508.702

6.  Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases.

Authors:  F C Ho; D Choy; S L Loke; I T Kung; K H Fu; R Liang; D Todd; R K Khoo
Journal:  Hum Pathol       Date:  1990-10       Impact factor: 3.466

Review 7.  The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.

Authors:  Yok-Lam Kwong
Journal:  J Clin Exp Hematop       Date:  2011

Review 8.  The dilemma of midline destructive lesions: a case series and diagnostic review.

Authors:  Noah P Parker; Aaron N Pearlman; David B Conley; Robert C Kern; Rakesh K Chandra
Journal:  Am J Otolaryngol       Date:  2009-03-27       Impact factor: 1.808

9.  Clinical analysis of extranodal non-Hodgkin's lymphoma in the sinonasal tract.

Authors:  J-S Woo; J M Kim; S H Lee; S W Chae; S J Hwang; H-M Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-25       Impact factor: 2.503

10.  Extranodal T-cell lymphoma of the sinonasal tract presenting as severe rhinitis: case series.

Authors:  Noah B Sands; Marc A Tewfik; Siew Yoong Hwang; Martin Desrosiers
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-08
View more
  1 in total

Review 1.  Natural Killer (NK)//T-Cell Lymphoma, Nasal Type, with Periorbital Involvement: A Case Report and Literature Review.

Authors:  Grażyna Lisowska; Natalia Zięba; Grażyna Stryjewska-Makuch; Wojciech Ścierski; Katarzyna Miśkiewicz-Orczyk; Maciej Misiołek
Journal:  Am J Case Rep       Date:  2020-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.